Skip to main content

The US Supreme Court and mifepristone







Court put on a bit of a show over the mifepristone litigation. Or, at least, the oral arguments were so widely and intensely followed it smelled a bit like a Barnum production. 

There is much that one might say about this dispute.  But this is the first time you will have seen anything about it in this humble blog, so for today I will just stick to some of the basics. 

Mifepristone is part of the standard medicinal protocol for  early-term abortions. Early here means within 70 days of a pregnant woman's last menstrual period. When it was first introduced in the United States the usual term was RU 486, and I am not sure when that more resonant term [it always sounds like a question, to be followed by "well, ARE YOU???"] lost favor. Was RU 486 a brand name? 

The percentage of abortions in the US that are medicinal rather than surgical has increased steadily since the approval of mifepristione here at the turn of the millennium. According to the CDC numbers, only 1% of abortions in 2000 were medicinal. But that was 10% in 2006, 24% by 2011, and a majority in 2020.  

The lawsuit now before SCOTUS was initiated roughly a year ago. Last April,  Judge Matthew Kacsmaryk issued a preliminary injunction suspending the 2000 approval. The Fifth Circuit almost immediatelt reversed parts of that injunction.  But not all. Specifically, the circuit court kept in place an injunction against changes in the relevant protocols (the Risk Evaluation and Mitigation Strategies) initiated by the FDA in 2016. 

The REMS for FDA approved drugs is not to be confused with the REM alt-rock band that was big in the 

The Supreme Court almost immediately stayed that injunction pending full consideration. Only two Justices dissented from that stay, Alito and Thomas. 

The argument last week was mostly about the issue of standing.  The plaintiffs in this case don't have any. Indeed, on that issue the oral argument seems to indicate that the plaintiffs have lost a vote in recent months, because Thomas was incredulous about the matter of standing. 

It looks very likely that the matter will be sent back to the trial court with instructions to dismiss for lack of standing, probably on an 8 to 1 vote. 

Labels:

Comments

Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.   We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a maj...
9 comments
Read more

Searle: The Chinese Room

John Searle has become the object of accusations of improper conduct. These accusations even have some people in the world of academic philosophy saying that instructors in that world should try to avoid teaching Searle's views. That is an odd contention, and has given rise to heated exchanges in certain corners of the blogosphere.  At Leiter Reports, I encountered a comment from someone describing himself as "grad student drop out." GSDO said: " This is a side question (and not at all an attempt to answer the question BL posed): How important is John Searle's work? Are people still working on speech act theory or is that just another dead end in the history of 20th century philosophy? My impression is that his reputation is somewhat inflated from all of his speaking engagements and NYRoB reviews. The Chinese room argument is a classic, but is there much more to his work than that?" I took it upon myself to answer that on LR. But here I'll tak...
17 comments
Read more

Recent Controversies Involving Nassim Taleb, Part I

I've written about Nassim Taleb on earlier occasions in this blog. I'll let you do the search yourself, dear reader, for the full background. The short answer to the question "who is Taleb?" is this: he is a 57 year old man born in Lebanon, educated in France, who has been both a hedge fund manager and a derivatives trader. He retired from active participation from the financial world sometime between 2004 and 2006, and has been a full-time writer and provocateur ever since. Taleb's writings for the general public began where one might expect -- in the field where he had made his money -- and he explained certain financial issues to a broad audiences in a very dramatic non-technical way. Since then, he has widened has fields of study, writing about just about everything, applying the intellectual tools he honed in that earlier work. As you might have gather from the above, I respect Taleb, though I have sometimes been critical of him when my own writing ab...
4 comments
Read more